Pancreatic Cancer Research

ResearcherLanzhou University Second HospitalActive in the last 2 years

Zuoyi Jiao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8090-1279; OpenAlex author ID A5100669867. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
4
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Polyphenol-based pH-responsive nanoparticles enhance chemo-immunotherapy in pancreatic cancer. Last author DOI 10.1016/j.jconrel.2025.02.021↗
  2. [Research progress in epidemiology, diagnosis and treatment for pancreatic cancer]. Last author DOI 10.11817/j.issn.1672-7347.2017.06.018↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jieru Li · 1 shared paper, 2025 · strength 0.28
  2. Yuman Dong · 1 shared paper, 2025 · strength 0.28
  3. Yiwei Dai · 1 shared paper, 2025 · strength 0.28
  4. Zankai Wu · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.